On the 23rd (local time) in San Diego, where BIO USA 2026 is held, employees of Korea Exchange (KRX), together with the Seoul Foundation for Strategic Investment, explain the KOSDAQ listing procedures for foreign companies to about 150 executives and staff of global biotech firms. /Courtesy of Korea Exchange (KRX)

Korea Exchange (KRX) visited the western United States to court listings on the domestic stock market and promote Korea's capital market to top global corporations.

Korea Exchange (KRX) said on the 24th that on the 23rd local time in San Diego, where "BIO USA 2026" was held, it hosted an event inviting officials from global bio corporations to promote Korea's capital market.

BIO USA is the world's largest exhibition in the bio and pharmaceutical fields, with about 20,000 participants from 72 countries as of last year.

At this event, Korea Exchange (KRX), together with the Seoul Business Agency, provided about 150 attendees with detailed guidance on systems related to initial public offerings (IPO), including the KOSDAQ listing process for foreign corporations.

In particular, the briefing featured a panel discussion with a large participation of IPO specialist institutions, including investment banks (IB) Samsung Securities and Eugene Investment & Securities, venture capital (VC) firm Korea Investment Partners, Yoon & Yang LLC, and Samil Accounting Corporation.

Korea Exchange (KRX) also focused on customized outreach by holding individual one-on-one meetings with promising local corporations to introduce the KOSDAQ technology exception listing system.

Min Gyeong-uk, a vice president at Korea Exchange (KRX), said, "Korea Exchange will continue sustained efforts and tailored outreach to invigorate domestic listings by overseas corporations so that KOSDAQ can establish itself as a global market."

※ This article has been translated by AI. Share your feedback here.